| 标题 |
Phase I, first-in-human study of futibatinib, a highly selective, irreversible FGFR1–4 inhibitor in patients with advanced solid tumors |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of Oncology 作者:R. Bahleda; F. Meric-Bernstam; L. Goyal; B. Tran; Y. He; et al 出版日期:2020-10-01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)